Ignite Creation Date:
2024-05-06 @ 8:01 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06225427
Status:
RECRUITING
Last Update Posted:
2024-06-26
First Post:
2024-01-13
Brief Title:
Gilteritinib for the Treatment of ALK NSCLC
Sponsor:
Organization:
University of Michigan Rogel Cancer Center